Home / Import refusals / NUV-3852229-1/110002/1

FDA Import Refusal NUV-3852229-1/110002/1 — Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

The FDA refused shipment NUV-3852229-1/110002/1 from Novo Nordisk Pharmaceutical Industries LP (United States) on November 4, 2025. The refused product falls under Drugs and Biologics — INSULIN DEGLUDEC. Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58HCP07 INSULIN DEGLUDEC
Charges
179

Recent inspections

  • 1269778 (NAI Fri Jun 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041878 (NAI Fri Jan 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035563 (NAI Thu Jan 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 892098 (NAI Thu Aug 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 802592 (NAI Thu Aug 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • NUV-3852229-1/60002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/70002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/80002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/90002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/50002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources